Sign in to continue:

Wednesday, May 6th, 2026

Addus HomeCare Corp Reports Strong Q1 2026 Financial Results – SEC 10-Q Filing Highlights Revenue Growth and Solid Earnings





Addus HomeCare Corporation Q1 2026 Financial Report: Investor Analysis

Addus HomeCare Corporation Q1 2026 Financial Report: Detailed Investor Analysis

Key Highlights from Q1 2026 Report

  • Quarter End: March 31, 2026
  • Common Stock Outstanding: 18,664,776 shares as of April 28, 2026
  • Reporting Status: Large Accelerated Filer, fully compliant with SEC filing requirements
  • Exchange: Nasdaq, Trading Symbol: ADUS
  • Total Assets: \$1,437,308,000
  • Total Stockholders’ Equity: \$1,116,160,000
  • Net Income (Q1 2026): \$25,125,000
  • Basic Earnings Per Share (Q1 2026): \$1.38
  • Diluted Earnings Per Share (Q1 2026): \$1.36
  • Retained Earnings: \$497,409,000
  • Additional Paid-In Capital: \$618,732,000
  • Common Stock Value: \$19,000
  • Shares Authorized: 40,000,000
  • Shares Issued: 18,665,000
  • Weighted Average Shares Outstanding (Basic): 18,194,000
  • Weighted Average Shares Outstanding (Diluted): 18,486,000

Important Shareholder Information & Potential Price-Sensitive Updates

  • Strong Earnings Growth: Net income for Q1 2026 was \$25.1 million, representing a substantial increase from \$21.2 million in Q1 2025. Basic EPS rose to \$1.38 from \$1.18, and diluted EPS climbed to \$1.36 from \$1.16, signaling robust profitability and improved margins. This growth could positively influence share price as investors respond to the company’s accelerating earnings trajectory.
  • Balance Sheet Strength: Stockholders’ equity increased to \$1.12 billion from \$1.09 billion at year-end 2025, with retained earnings up from \$472.3 million to \$497.4 million. This demonstrates continued financial stability and potential for future dividend or buyback considerations, which are generally favorable for share valuation.
  • Share Issuances & Stock-Based Compensation: The company issued 126,000 shares under restricted stock award agreements and 21,000 shares through stock option exercises in Q1 2026. This modest dilution is offset by strong earnings, but investors should monitor ongoing share-based compensation trends.
  • Compliance & Growth Status: Addus is not a shell company, not an emerging growth company, and remains a large accelerated filer. This communicates regulatory stability and maturity, reducing risk factors for institutional investors.
  • Operating Income: Operating income for Q1 2026 was \$35.2 million, up from \$30.3 million in Q1 2025. This operational improvement is a key driver for long-term share value.
  • Market Sensitivity: The company’s improved Q1 profitability, rising equity, and continuing stock-based compensation are all relevant to investors considering share price movements. With strong financials and growth, the report contains newsworthy data likely to influence market sentiment.

Detailed Financial Breakdown

Quarterly Financial Comparison
Metric Q1 2026 Q1 2025
Net Income \$25,125,000 \$21,228,000
Operating Income \$35,224,000 \$30,357,000
Basic Earnings Per Share \$1.38 \$1.18
Diluted Earnings Per Share \$1.36 \$1.16
Weighted Average Shares (Basic) 18,194,000 17,976,000
Weighted Average Shares (Diluted) 18,486,000 18,311,000
Stockholders’ Equity \$1,116,160,000 \$1,085,303,000 (Year-end 2025)
Retained Earnings \$497,409,000 \$472,340,000 (Year-end 2025)
Additional Paid-In Capital \$618,732,000 \$612,945,000 (Year-end 2025)
Common Stock Issued 18,665,000 18,518,000 (Year-end 2025)

Conclusion

Addus HomeCare Corporation’s Q1 2026 financial report demonstrates strong earnings growth, increasing equity, and robust operational performance. The company’s healthy balance sheet, continued compliance, and ongoing share issuances are all important for shareholders and may affect the share price positively. Investors should pay close attention to the company’s expansion of retained earnings and rising EPS, both of which are likely to influence market sentiment and valuation.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should perform their own due diligence and consult with a financial advisor before making any investment decisions. The information presented is based on the company’s public filings as of March 31, 2026 and may be subject to change.




View Addus HomeCare Corp Historical chart here



REVOLVE GROUP, INC. 8-K Filing March 2026: Director Departure, NYSE Listing, Company Information

Revolve Group, Inc. 8-K Filing: Board Changes Announced ...

M-tron Industries, Inc. Announces Extension of Rights Offering – Company Details, Stock Info, and SEC Filing Summary

M-tron Industries, Inc. Announces Extension of Rights Offeri...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today